Australia markets close in 58 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.93-0.82 (-6.98%)
At close: 04:00PM EST
11.08 +0.15 (+1.37%)
After hours: 07:46PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
37,916
37,916
32,984
25,232
22,260
Selling general and administrative
13,070
13,070
9,018
5,857
6,847
Total operating expenses
50,986
50,986
41,947
30,938
28,808
Operating income or loss
-50,986
-50,986
-41,947
-30,938
-28,808
Total other income/expenses net
2,419
2,419
4,280
4,501
2,539
Income before tax
-47,619
-47,619
-37,641
-26,258
-26,213
Income tax expense
358.492
358.492
267.565
22.664
82.181
Income from continuing operations
-47,978
-47,978
-37,909
-26,280
-26,295
Net income
-47,978
-47,978
-37,909
-26,280
-26,295
Net income available to common shareholders
-47,978
-47,978
-37,909
-26,280
-26,295
Basic EPS
-
-
-0.54
-0.45
-0.54
Diluted EPS
-
-
-0.54
-0.45
-0.54
Basic average shares
-
-
69,803
58,195
48,906
Diluted average shares
-
-
69,803
58,195
48,906
EBITDA
-
-50,986
-41,947
-30,938
-28,808